DEXEDRINE

This brand name is authorized in Canada, United States

Active ingredients

The drug DEXEDRINE contains one active pharmaceutical ingredient (API):

1 Dexamfetamine
UNII JJ768O327N - DEXTROAMPHETAMINE SULFATE

Amphetamines are non-catecholamine, sympathomimetic amines with CNS stimulant activity. Peripheral actions include elevations of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action.

Read about Dexamfetamine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
DEXEDRINE SPANSULE Extended-release capsule FDA, National Drug Code (US) MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N06BA02 Dexamfetamine N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BA Centrally acting sympathomimetics
Discover more medicines within N06BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 01924516, 01924559, 01924567
Country: US FDA, National Drug Code Identifier(s): 64896-673, 64896-674, 64896-675

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.